OCUP $3.90 -FDA Decision in September and has another 3x Phase 3 trials with some readouts in Q4 - Market Cap only $80 m and cash balance is at $39 m another $10 million milestone payment expected upon FDA approval by partner Viatris (VTRS) .
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.